Cash flow Ind-Swift Laboratories Limited

Stocks

INDSWFTLAB

INE915B01019

Pharmaceuticals

Delayed NSE India S.E. 15:05:08 01/10/2026 +04			5-day change	1st Jan Change
395.15 ^INR	+1.65%		-1.52%	+348.27%

09-17	Ind-Swift Laboratories Limited announced that it has received INR 343 million in funding from Essix Biosciences Limited	CI
08-18	Ind-Swift Laboratories Limited Is Upgrading the Manufacturing Facility Located At Jammu	CI

9ae93708ded7314edf1.MmDoyPkaFN_0aiDitOFA6z5tD9Riz5JYJt9iTe3PU-0.ZjOdnY9OR4eEJ2u33LEpmgYXXLUrv6JsRe4yPZ2rC45KLJ_5s1gjstkLbQ

Published financial data: IND-SWIFT LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Revenues	10.39B	12.07B	12.81B	5.62B	6.49B
Other Revenues, Total	134M	86.24M	164M	-	-
Total Revenues	10.52B	12.16B	12.97B	5.62B	6.49B
Cost of Goods Sold, Total	5.27B	6.56B	6.61B	2.88B	2.88B
Gross Profit	5.26B	5.6B	6.36B	2.74B	3.61B
Selling General & Admin Expenses, Total	1.15B	1.4B	1.58B	1.25B	1.46B
Depreciation & Amortization - (IS)	1.31B	574M	533M	245M	306M
Other Operating Expenses	1.87B	1.81B	2.09B	1.68B	1.68B
Other Operating Expenses, Total	4.33B	3.79B	4.21B	3.18B	3.45B
Operating Income	924M	1.82B	2.15B	-439M	164M
Interest Expense, Total	-915M	-864M	-467M	-13.83M	-1.94M
Interest And Investment Income	5.62M	58.72M	184M	383M	555M
Net Interest Expenses	-909M	-805M	-283M	369M	553M
Income (Loss) On Equity Invest.	-	-2.34M	-4.9M	-517K	977K
Currency Exchange Gains (Loss)	148M	181M	106M	103M	-
Other Non Operating Income (Expenses)	99.16M	-48.57M	-43.32M	25.36M	-97.36M
EBT, Excl. Unusual Items	262M	1.14B	1.92B	58.2M	620M
Gain (Loss) On Sale Of Assets	-65.66M	-613K	22.35M	287M	-1.73M
Asset Writedown	-71.01M	-10M	-	-	-
Insurance Settlements	-	-	-	-	-
Other Unusual Items	-	-266M	3.87B	2.23B	-110M
EBT, Incl. Unusual Items	125M	863M	5.81B	2.58B	509M
Income Tax Expense	147M	387M	1.6B	72.7M	77.3M
Earnings From Continuing Operations	-21.49M	476M	4.21B	2.5B	431M
Net Income to Company	-21.49M	476M	4.21B	2.5B	431M
Net Income - (IS)	-21.49M	476M	4.21B	2.5B	431M
Net Income to Common Incl Extra Items	-21.49M	476M	4.21B	2.5B	431M
Net Income to Common Excl. Extra Items	-21.49M	476M	4.21B	2.5B	431M
Per Share Items
Net EPS - Basic	-0.36	8.06	71.24	37.25	5.16
Basic EPS - Continuing Operations	-0.36	8.06	71.24	37.25	5.16
Basic Weighted Average Shares Outstanding	59.09M	59.09M	59.09M	67.24M	83.64M
Net EPS - Diluted	-0.36	8.06	71.24	35.21	5.03
Diluted EPS - Continuing Operations	-0.36	8.06	71.24	35.21	5.03
Diluted Weighted Average Shares Outstanding	59.09M	59.09M	59.09M	71.14M	85.66M
Normalized Basic EPS	2.77	12.06	20.36	0.54	4.64
Normalized Diluted EPS	2.77	12.06	20.36	0.51	4.53
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	2.22B	2.39B	2.68B	-218M	445M
EBITA	924M	1.82B	2.15B	-439M	164M
EBIT	924M	1.82B	2.15B	-439M	164M
EBITDAR	2.23B	2.4B	2.69B	-201M	471M
Total Revenues (As Reported)	10.81B	12.41B	13.26B	6.43B	6.96B
Effective Tax Rate - (Ratio)	117.15	44.84	27.58	2.82	15.2
Total Current Taxes	248M	151M	1.71B	77.44M	131M
Total Deferred Taxes	-109M	234M	-108M	-38.23M	-54.02M
Normalized Net Income	164M	712M	1.2B	36.38M	388M
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	886M	836M	452M	13.83M	2.18M
Non-Cash Pension Expense	8.74M	8.74M	13.39M	7.19M	10.04M
Supplemental Operating Expense Items
Advertising Expense	2.36M	34.92M	45.55M	60.16M	50.74M
Selling and Marketing Expenses	2.36M	34.92M	45.55M	60.16M	50.74M
Research And Development Expense From Footnotes	327M	426M	355M	23.05M	39.15M
Net Rental Expense, Total	5.16M	7.45M	8.64M	16.35M	25.99M
Imputed Operating Lease Interest Expense	3.85M	5.67M	7.34M	1.4M	1.31M
Imputed Operating Lease Depreciation	1.3M	1.78M	1.29M	14.95M	24.68M
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	18.5M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	-	-	-	-	18.5M

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Assets
Cash And Equivalents	215M	182M	4.32B	4.28B	4.3B
Short Term Investments	-	-	-	394M	119M
Total Cash And Short Term Investments	215M	182M	4.32B	4.67B	4.42B
Accounts Receivable, Total	4.55B	5.05B	1.69B	1.65B	1.99B
Other Receivables	392M	250M	90.98M	407M	149M
Notes Receivable	-	968M	1.7M	5.16M	400M
Total Receivables	4.94B	6.27B	1.78B	2.06B	2.53B
Inventory	4.29B	4.39B	105M	1.14B	1.48B
Prepaid Expenses	50.28M	40.69M	-	10.06M	19.81M
Other Current Assets, Total	1.27B	765M	404M	770M	1.32B
Total Current Assets	10.76B	11.65B	6.61B	8.65B	9.77B
Gross Property Plant And Equipment	13.28B	13.39B	81.31M	5.68B	6.1B
Accumulated Depreciation	-6.91B	-7.46B	-27.68M	-3.08B	-3.23B
Net Property Plant And Equipment	6.37B	5.93B	53.64M	2.6B	2.87B
Long-term Investments	291M	303M	1.11B	1.74B	2.36B
Goodwill	351K	-	-	-	-
Other Intangibles, Total	10M	-	-	107M	275M
Loans Receivable Long-Term	-	-	3.53B	735M	735M
Deferred Tax Assets Long-Term	519M	299M	319M	446M	503M
Other Long-Term Assets, Total	56.16M	65.96M	27.87M	99.59M	231M
Total Assets	18.01B	18.24B	11.65B	14.38B	16.73B
Liabilities
Accounts Payable, Total	1.76B	2.04B	940M	1.1B	1.46B
Accrued Expenses, Total	186M	213M	99.66M	663M	684M
Short-term Borrowings	640M	492M	27.11M	55.55M	63.17M
Current Portion of Long-Term Debt	407M	598M	27.48M	93.51M	18.66M
Current Portion of Leases	270K	270K	-	154K	154K
Current Income Taxes Payable	53.88M	123M	1.02B	42.09M	704K
Unearned Revenue Current, Total	252K	253K	-	-	-
Other Current Liabilities	298M	246M	101M	249M	348M
Total Current Liabilities	3.35B	3.71B	2.21B	2.21B	2.57B
Long-Term Debt	8.48B	7.53B	112M	257M	121M
Long-Term Leases	5.06M	5.32M	-	2.27M	1.95M
Unearned Revenue Non Current	1.49M	1.23M	-	74.92M	-
Pension & Other Post Retirement Benefits	140M	148M	10.32M	91.29M	107M
Other Non Current Liabilities	30.24M	29.45M	1.95M	22.38M	91.44M
Total Liabilities	12B	11.42B	2.34B	2.65B	2.89B
Common Stock, Total	591M	591M	591M	687M	868M
Additional Paid In Capital	3.07B	3.07B	3.07B	3.95B	5.96B
Retained Earnings	738M	1.36B	5.69B	1.35B	1.64B
Comprehensive Income and Other	1.61B	1.8B	-37.77M	5.73B	5.37B
Total Common Equity	6.01B	6.82B	9.31B	11.73B	13.84B
Minority Interest	-1.1M	-	-171K	-348K	-575K
Total Equity	6.01B	6.82B	9.31B	11.73B	13.84B
Total Liabilities And Equity	18.01B	18.24B	11.65B	14.38B	16.73B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	59.09M	59.09M	59.09M	68.74M	86.84M
ECS Total Common Shares Outstanding	59.09M	59.09M	59.09M	68.74M	86.84M
Book Value / Share	101.71	115.41	157.64	170.63	159.38
Tangible Book Value	6B	6.82B	9.31B	11.62B	13.57B
Tangible Book Value Per Share	101.53	115.41	157.64	169.08	156.22
Total Debt	9.53B	8.62B	166M	409M	205M
Net Debt	9.32B	8.44B	-4.15B	-4.27B	-4.21B
Debt Equivalent of Unfunded Proj. Benefit Obligation	167M	183M	-178M	105M	129M
Debt Equivalent Oper. Leases	41.26M	59.61M	69.11M	131M	208M
Minority Interest, Total (Incl. Fin. Div)	-1.1M	-	-171K	-348K	-575K
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	1.08B	1.08B	2.18M	817M	881M
Inventories - Work In Process, Total	1.91B	1.89B	-	103M	144M
Inventories - Finished Goods, Total	1.17B	1.28B	102M	206M	434M
Inventories - Others	115M	129M	-	15.86M	19.88M
Land - (BS)	541M	539M	-	264M	265M
Buildings, Total	2.69B	2.7B	-	1.37B	1.37B
Machinery, Total	9.94B	10.05B	81.31M	3.78B	4.1B
Full Time Employees	1.45K	1.5K	47	1.25K	1.39K
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	526M	505M

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Net Income	-21.49M	476M	4.21B	2.5B	431M
Depreciation & Amortization - CF	1.3B	574M	533M	221M	282M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	74K	74K
Depreciation & Amortization, Total	1.3B	574M	533M	221M	282M
Amortization of Deferred Charges, Total - (CF)	10.6M	-	-	23.96M	24.44M
(Gain) Loss From Sale Of Asset	30.05M	10.61M	225M	-287M	1.73M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	74.64M
Stock-Based Compensation (CF)	-	-	-	-	18.5M
Provision and Write-off of Bad Debts	-	-	248M	16.7M	-14.2M
Other Operating Activities, Total	1.06B	1.4B	-2.02B	-2.54B	-466M
Change In Accounts Receivable	-262M	-367M	-1.12B	968M	-403M
Change In Inventories	-528M	-101M	329M	-432M	-338M
Change In Income Taxes	-	-	-	-	-
Change in Other Net Operating Assets	-89.06M	-45.44M	-4.04B	-734M	-293M
Cash from Operations	1.5B	1.95B	-1.63B	-255M	-682M
Capital Expenditure	-184M	-128M	-445M	-644M	-877M
Sale of Property, Plant, and Equipment	54.98M	1.45M	29.46M	386M	11.9M
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	171M	-12.73M	-811M	-1.26B	-416M
Other Investing Activities, Total	5.62M	5.31M	184M	420M	555M
Cash from Investing	47.72M	-134M	-1.04B	-1.1B	-727M
Short Term Debt Issued, Total	-	-	-	276M	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	276M	-
Long-Term Debt Repaid, Total	-360M	-459M	-374M	-66.04M	-151M
Total Debt Repaid	-360M	-459M	-374M	-66.04M	-151M
Issuance of Common Stock	-	-	-	926M	1.63B
Other Financing Activities, Total	-1.05B	-1.4B	7.36B	-444M	-62.23M
Cash from Financing	-1.41B	-1.86B	6.99B	692M	1.42B
Foreign Exchange Rate Adjustments	-	-	-	-	37.79M
Miscellaneous Cash Flow Adjustments	-	-1K	-	-	-
Net Change in Cash	142M	-44.06M	4.31B	-659M	47.36M
Supplemental Items
Cash Interest Paid	1.05B	1.29B	1.26B	419M	54.77M
Cash Income Tax Paid (Refund)	-	112M	728M	32.17M	67.01M
Levered Free Cash Flow	269M	440M	9.85B	-2.1B	-1.36B
Unlevered Free Cash Flow	841M	980M	10.14B	-2.09B	-1.36B
Change In Net Working Capital	863M	601M	-8.71B	1.42B	907M
Net Debt Issued / Repaid	-360M	-459M	-374M	210M	-151M

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Profitability
Return on Assets	3.19	6.26	8.99	-1.89	0.66
Return on Total Capital	3.65	7.32	10.79	-2.44	0.78
Return On Equity %	-0.36	7.42	52.18	25.24	3.37
Return on Common Equity	-0.36	7.42	52.18	25.24	3.37
Margin Analysis
Gross Profit Margin %	49.95	46.08	49.01	48.74	55.63
SG&A Margin	10.94	11.52	12.2	22.28	22.52
EBITDA Margin %	21.13	19.64	20.68	-3.88	6.86
EBITA Margin %	8.78	14.93	16.58	-7.81	2.52
EBIT Margin %	8.78	14.93	16.58	-7.81	2.52
Income From Continuing Operations Margin %	-0.2	3.91	32.45	44.59	6.64
Net Income Margin %	-0.2	3.91	32.45	44.59	6.64
Net Avail. For Common Margin %	-0.2	3.91	32.45	44.59	6.64
Normalized Net Income Margin	1.56	5.86	9.27	0.65	5.97
Levered Free Cash Flow Margin	2.56	3.62	75.91	-37.38	-20.93
Unlevered Free Cash Flow Margin	7.99	8.06	78.16	-37.23	-20.91
Asset Turnover
Asset Turnover	0.58	0.67	0.87	0.39	0.42
Fixed Assets Turnover	1.52	1.98	4.34	2.29	2.38
Receivables Turnover (Average Receivables)	2.34	2.51	3.8	2.35	3.58
Inventory Turnover (Average Inventory)	1.31	1.51	2.95	3.05	2.2
Short Term Liquidity
Current Ratio	3.22	3.14	2.99	3.92	3.8
Quick Ratio	1.54	1.48	2.76	3.05	2.55
Operating Cash Flow to Current Liabilities	0.45	0.52	-0.74	-0.12	-0.26
Days Sales Outstanding (Average Receivables)	155.87	145.13	96.36	155.14	102.07
Days Outstanding Inventory (Average Inventory)	278.7	241.38	124.24	119.61	166.07
Average Days Payable Outstanding	99.14	104.16	233.71	224.59	145.24
Cash Conversion Cycle (Average Days)	335.43	282.35	-13.12	50.16	122.9
Long Term Solvency
Total Debt/Equity	158.61	126.42	1.78	3.48	1.48
Total Debt / Total Capital	61.33	55.83	1.75	3.37	1.46
LT Debt/Equity	141.18	110.44	1.2	2.21	0.89
Long-Term Debt / Total Capital	54.59	48.78	1.18	2.14	0.88
Total Liabilities / Total Assets	66.63	62.61	20.06	18.45	17.29
EBIT / Interest Expense	1.01	2.1	4.61	-31.71	84.57
EBITDA / Interest Expense	2.43	2.77	5.75	-15.75	230.04
(EBITDA - Capex) / Interest Expense	2.23	2.62	4.79	-62.32	-223.07
Total Debt / EBITDA	4.29	3.61	0.06	-1.88	0.46
Net Debt / EBITDA	4.19	3.53	-1.55	19.59	-9.46
Total Debt / (EBITDA - Capex)	4.67	3.81	0.07	-0.47	-0.47
Net Debt / (EBITDA - Capex)	4.57	3.73	-1.86	4.95	9.75
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	16.03	15.48	6.69	-67.14	13.04
Gross Profit, 1 Yr. Growth %	15.42	8.7	13.46	-67.38	26.13
EBITDA, 1 Yr. Growth %	12.16	6.89	12.33	-107.11	-748.02
EBITA, 1 Yr. Growth %	-16.72	96.4	18.46	-119.41	-156.63
EBIT, 1 Yr. Growth %	-16.72	96.4	18.46	-119.42	-152.26
Earnings From Cont. Operations, 1 Yr. Growth %	-31.72	-2.31K	784.44	-53.51	-82.78
Net Income, 1 Yr. Growth %	-31.72	-2.31K	784.44	-53.51	-82.78
Normalized Net Income, 1 Yr. Growth %	45.48	335.12	68.81	-96.5	89.72
Diluted EPS Before Extra, 1 Yr. Growth %	-31.72	-2.31K	784.38	-61.38	-85.71
Accounts Receivable, 1 Yr. Growth %	5.18	11.11	-66.53	-47.43	20.68
Inventory, 1 Yr. Growth %	14.06	2.36	-97.62	53.16	29.56
Net Property, Plant and Equip., 1 Yr. Growth %	-14.87	-6.92	-99.1	13.01	10.17
Total Assets, 1 Yr. Growth %	-0.97	1.29	-36.13	-1.51	16.34
Tangible Book Value, 1 Yr. Growth %	0.98	13.66	36.59	45.01	16.71
Common Equity, 1 Yr. Growth %	-0.42	13.47	36.59	44.44	17.99
Cash From Operations, 1 Yr. Growth %	11.36	29.51	-183.81	-86.38	137.6
Capital Expenditures, 1 Yr. Growth %	370.92	-30.65	248.59	-11.79	36.2
Levered Free Cash Flow, 1 Yr. Growth %	10	57.48	2.14K	-122.79	-33.75
Unlevered Free Cash Flow, 1 Yr. Growth %	1.52	15.14	935.12	-121.29	-33.53
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	14.73	15.8	11	-32.03	-38.37
Gross Profit, 2 Yr. CAGR %	14.24	10.93	11.06	-30.1	-34.41
EBITDA, 2 Yr. CAGR %	16.44	9.76	9.58	-69.81	-61.88
EBITA, 2 Yr. CAGR %	11.78	27.9	52.53	-50.85	-73.07
EBIT, 2 Yr. CAGR %	11.78	27.9	52.53	-50.85	-73.08
Earnings From Cont. Operations, 2 Yr. CAGR %	-68.15	288.89	1.3K	129.4	-71.71
Net Income, 2 Yr. CAGR %	-68.15	288.89	1.3K	129.4	-71.71
Normalized Net Income, 2 Yr. CAGR %	14.92	151.6	171.03	-77.4	-38.89
Diluted EPS Before Extra, 2 Yr. CAGR %	-70.86	288.89	1.3K	109.07	-76.51
Accounts Receivable, 2 Yr. CAGR %	7.11	8.1	-39.02	-42.94	-20.35
Inventory, 2 Yr. CAGR %	11.8	8.05	-84.38	-48.98	40.87
Net Property, Plant and Equip., 2 Yr. CAGR %	-10.69	-10.99	-90.82	-33.76	11.58
Total Assets, 2 Yr. CAGR %	-1.87	0.15	-19.56	-11.2	7.04
Tangible Book Value, 2 Yr. CAGR %	0.03	7.14	24.6	30.55	30.09
Common Equity, 2 Yr. CAGR %	-3.15	6.3	24.5	31.15	30.55
Cash From Operations, 2 Yr. CAGR %	9.54	20.09	4.18	-63.82	-39.62
Capital Expenditures, 2 Yr. CAGR %	30.92	80.72	55.48	124.57	9.61
Levered Free Cash Flow, 2 Yr. CAGR %	4.83	34.09	493.94	118.54	-61.6
Unlevered Free Cash Flow, 2 Yr. CAGR %	-2.55	8.77	245.24	46.1	-62.83
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10.54	15.01	12.68	-18.9	-18.88
Gross Profit, 3 Yr. CAGR %	11.84	11.64	11.77	-19.02	-13.62
EBITDA, 3 Yr. CAGR %	14.4	13.35	10.61	-53.98	-42.88
EBITA, 3 Yr. CAGR %	27.59	34.89	24.68	-22	-55.15
EBIT, 3 Yr. CAGR %	27.59	34.89	24.68	-22	-55.15
Earnings From Cont. Operations, 3 Yr. CAGR %	-57.97	30.97	411.41	388.48	-3.24
Net Income, 3 Yr. CAGR %	-57.97	30.97	411.41	388.48	-3.24
Normalized Net Income, 3 Yr. CAGR %	-7.61	79.12	120.26	-39.44	-18.36
Diluted EPS Before Extra, 3 Yr. CAGR %	-60.64	23.43	411.4	359.17	-14.53
Accounts Receivable, 3 Yr. CAGR %	9.03	8.42	-26.87	-28.75	-26.76
Inventory, 3 Yr. CAGR %	10.61	8.56	-69.69	-35.65	-30.39
Net Property, Plant and Equip., 3 Yr. CAGR %	-8.99	-9.45	-80.72	-25.81	-21.52
Total Assets, 3 Yr. CAGR %	-2.18	-0.83	-13.79	-7.22	-2.83
Tangible Book Value, 3 Yr. CAGR %	5.45	4.38	16.17	24.66	25.77
Common Equity, 3 Yr. CAGR %	0.74	2.1	15.57	24.97	26.61
Cash From Operations, 3 Yr. CAGR %	32.64	15.83	6.52	-44.66	-29.51
Capital Expenditures, 3 Yr. CAGR %	6.47	5.93	124.96	51.79	90.09
Levered Free Cash Flow, 3 Yr. CAGR %	-37.33	21.56	242.78	95.93	45.66
Unlevered Free Cash Flow, 3 Yr. CAGR %	13.95	3.44	130.5	34.95	11.49
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	8.06	9.37	10.74	-6.81	-6.47
Gross Profit, 5 Yr. CAGR %	10.29	7.72	11.1	-7.43	-4.53
EBITDA, 5 Yr. CAGR %	12.62	9.93	12.55	-33.22	-25.82
EBITA, 5 Yr. CAGR %	21.78	23.91	37.04	-9.93	-31.79
EBIT, 5 Yr. CAGR %	21.78	23.91	37.04	-9.92	-31.8
Earnings From Cont. Operations, 5 Yr. CAGR %	-44.03	16.71	70.82	63.88	68.8
Net Income, 5 Yr. CAGR %	-44.03	16.71	70.82	63.88	68.8
Normalized Net Income, 5 Yr. CAGR %	-12.1	24.62	42.09	-21.75	28.06
Diluted EPS Before Extra, 5 Yr. CAGR %	-47.59	10.56	64.23	52.39	56.68
Accounts Receivable, 5 Yr. CAGR %	4.94	4.38	-13.58	-16.13	-14.42
Inventory, 5 Yr. CAGR %	4.52	6.72	-49.44	-19.74	-17.01
Net Property, Plant and Equip., 5 Yr. CAGR %	-6.54	-7.26	-63.65	-20.1	-17.46
Total Assets, 5 Yr. CAGR %	-3.37	-2.05	-9.54	-5.11	-1.65
Tangible Book Value, 5 Yr. CAGR %	13.06	9.8	12.73	14.16	17.96
Common Equity, 5 Yr. CAGR %	2.49	4.27	9.64	12.86	18.06
Cash From Operations, 5 Yr. CAGR %	9.48	21.64	20.43	-27.28	-12.77
Capital Expenditures, 5 Yr. CAGR %	-1.83	-8.99	23.89	43.07	86.28
Levered Free Cash Flow, 5 Yr. CAGR %	-35.08	-13.26	55.22	53.7	40.92
Unlevered Free Cash Flow, 5 Yr. CAGR %	-21.38	-1.63	77.96	18.76	10.39